Cleveland Clinic 29th Annual Diabetes Day 2025
+ Include: 16 videos + 20 pdfs, size: 5.35 GB
+ Target Audience: endocrinologists, diabetes educators
+ Information:
The 29th Annual Diabetes Day: Therapeutics, Technology and Surgery is presented by the Cleveland Clinic Department of Endocrinology, Diabetes and Metabolism to provide up-to-date reviews of management strategies and research on the complications of diabetes. Key topic areas that will be addressed include:
- Review of therapeutic options to manage both Type 1 and 2 diabetes and their complications, including a pump update, and new insulins and continuous glucose monitoring updates.
- Importance of maintaining muscle mass during obesity management.
- Latest technology in insulin pumps
- New roles for GLP1 receptor agonists SGLT-2 inhibitors and mineralocorticoid receptor antagonists
- Complications of GLP-1 receptor agonists
This year’s curriculum will also feature discussions about:
- Glucose variability and diabetes
- Effects of high fat and high protein diets on glucose control
- Effects of GLP-1 on sleep apnea
- Nutritional supplements in treatment of DM2
The goal of this symposium is to increase practitioners’ competence and clinical performance in treating diabetes and its complications and, ultimately, to improve patient outcomes.
Attendees will be able to:
- Critically appraise clinical evidence and guidelines supporting hybrid closed-loop systems in pregnancy and identify key considerations when initiating and monitoring hybrid closed-loop pumps during pregnancy.
- Describe the efficacy of inhaled insulin to insulin pump therapy in diabetes management.
- Discuss the role of nutritional supplements in the management of Type 2 diabetes and glycemic control, including the use of berberine.
- Discuss future directions and challenges in developing and implementing oral GLP-1 agonists and multi-agonist therapy in diabetes care and summarize clinical evidence on the incidence and risk of gastroparesis, pancreatitis, and thyroid cancer associated with GLP-1 agonist use.
- Analyze current research and define treatment strategies for challenges in diabetes care, including dementia, blood pressure, including intensive blood pressure control, and cardiovascular and renal complications in diabetes.
- Discuss evidence-based treatment strategies for post-gastric bypass hypoglycemia, including dietary modifications, pharmacotherapy, and other interventions.
- Discuss practical considerations for initiating and titrating novel therapies such as efsitora alfa in different patient populations, including those with complex diabetes management needs.
Who should attend?
This activity is designed for physicians, diabetes educators, nurses, nurse practitioners, pharmacists, pharmacy technicians, physician assistants, residents and fellows, and other health care professionals who care for patients with diabetes.
+ Topics:
Thursday, May 22, 2025Â All times in Eastern Time |
|
|
7:00 am
|
Registration and Exhibits |
|
7:15 am
|
Non-CME Breakfast Session |
|
7:55 am
|
Welcome and Introduction Robert Zimmerman, MD |
|
8:00 am
|
New Technology: Equity and Access Sarah Macleish, DO |
|
8:30 am
|
Use of Hybrid Closed Loop Pumps in Pregnancy in DM 1 and DM 2Â Kevin Borst, DO |
|
8:50 am
|
Preventing Type 2 Diabetes: Current Management of Pre Diabetes Oscar Morey Vargus, MD |
|
9:10 am
|
Nutritional Supplements in Treatment of DM 2: Focus on Berberine Keren Zhou, MD |
|
9:30 am
|
Oral GLP-1 Receptor Agonists and Multi Agonist Therapy Robert Zimmerman, MD |
|
10:00 am
|
Refreshment Break and Exhibits |
|
10:15 am
|
Increased Risk of Demetia in Patients with Diabetes and How to Prevent Willy Valencia Rodrigo, MD |
|
10:35 am
|
Effect of Intensive BP Control in Diabetes. New insights from BP ROADÂ Dennis Bruemmer, MD, PhD |
|
11:00 am
|
Treatment of Post Gastric Bypass Hypoglycemia Lina Alkhaled, MD |
|
11:30 am
|
Complications of GLP-1 Receptor Agonists: Gastroparesis, Pancreatitis, Thyroid Cancer: What is the Data? Kevin Pantalone, DO |
|
12:00 pm
|
Ultra Long-acting Insulins Focus on Efsitora Alpha Ravali Veeramachaneni, MD |
|
12:30 pm
|
Concurrent Non-CME Lunch Presentations |
|
1:30 pm
|
Use of Insulin Pumps; Innovations in the Last Year Diana Isaacs, PharmD |
Concurrent Workshops2:05 pm Workshop 1 – CGM Workshop Cecilia Lansang, MD Kevin Malloy, DO Diana Isaacs, PharmD 2:05 pm Workshop 2 – Diabetes Distress: Simulation and Discussion Emily Durfey, MSW, LSW Stephanie Ash, MSW, LSW Keysha Ramsey, BSW, LSW 2:05 pm Workshop 3 – Prevention of Exercise Induced Hypoglycemia: Metoclopramide and Low Dose Glucagon Mona Gossman, MD 2:35 pm Screening for Diabetes Related Antibodies for Prevention of Type 1 Diabetes Leann Olansky, MD |
|
|
3:05 pm
|
Refreshment Break and Exhibits |
|
3:20 pm
|
Preserving Muscle Mass with Weight Loss with High Protein Diet Marcio Griebeler, MD |
|
3:45 pm
|
Implications of Glucose Variability on Chronic Complications of Diabetes Adi Mehta, MD |
|
4:15 pm
|
Effect of GLP-1/GIP Agonists on Sleep Apnea Marwan Hamaty, MD |
|
4:45 pm
|
MASH, NASH, NAFLD, MASLD: Who to Screen, How to Treat , When to Refer Yael Mauer, MD |
|
5:15 pm
|
Adjourn/Non-CME Reception |
Dr. Lisa M., Endocrinologist –
“This is the premier annual update for any serious diabetes clinician. The 2025 deep dive on retatrutide and the future of triagonists was worth the entire investment. Cleveland Clinic consistently delivers the frontier of care, not just the standard.”
Dr. David R., Hospital Endocrinology Director –
“The sessions on inpatient diabetes and steroid-induced hyperglycemia are masterclasses. As a hospital-based endocrinologist, these protocols have streamlined our consults and improved glycemic control metrics significantly.”
Dr. Anika P., Obesity Medicine Specialist –
“Finally, a course that treats obesity management as the cornerstone of diabetes care, not an afterthought. The practical algorithms for sequencing pharmacotherapy are what I’ve been searching for.”
Dr. James T., Family Medicine Physician –
“As a PCP, I’m expected to manage 90% of diabetes care. This course empowers me to do it confidently. The ‘Tech in 10 Minutes’ module demystified automated insulin delivery systems, so I can now have informed conversations with my patients.”
– Dr. Maria G., Internist –
“The cardio-renal-metabolic updates are presented with stunning clarity. I left with a clear, prioritized action plan for using SGLT2s and GLP-1s that I implemented in my clinic the very next Monday. Patient outcomes are already improving.”
Dr. Henry W., Geriatric Medicine –
“Managing diabetes in the elderly and frail is a constant challenge. The nuanced framework presented here on deprescribing, hypoglycemia avoidance, and realistic A1c targets is compassionate, evidence-based, and instantly usable.”
Chloe B., NP-C –
“The case-based workshops on ‘difficult-to-control’ diabetes are unparalleled. Walking through complex patient scenarios with Cleveland Clinic experts sharpens clinical reasoning in a way reading guidelines never could.”
Sarah K., RN, CDCES –
“As a Diabetes Care and Education Specialist (DCES), this course keeps me at the top of my game. The latest on smart pens and data interpretation allows me to provide cutting-edge education and truly partner with my patients on tech adoption.”
Mark L., PharmD, BCPS –
“The pharmacist-focused session on drug interactions, access, and titration schedules for new agents was incredibly detailed. It’s transformed how our pharmacy team supports both clinicians and patients.”
Dr. Alex C., Internal Medicine –
“The Google Drive access is a game-changer. I downloaded the PDF algorithms on MASLD management and postoperative care directly to my clinic iPad. They are now my go-to references during patient visits.”
Dr. Priya N., Primary Care Physician –
“I’ve attended many diabetes conferences. This one stands out for its zero-fluff, high-yield format. Every lecture is packed with ‘what to do on Monday’ advice. The production quality is also exceptional.”
Dr. Ben S., Community Health Center Medical Director –
“For clinicians in resource-limited settings, this course is vital. It teaches you how to maximize outcomes with available tools and provides a clear roadmap for when to refer. Incredibly practical and equitable in its approach.”
Dr. Elena V., Medical Director –
“This annual update directly improves our clinic’s quality metrics. After implementing the structured foot exam and neuropathy screening protocol, we identified several ‘silent’ complications early. This course pays for itself in improved patient safety.”
Dr. Tom R., Endocrinologist –
“In a world of information overload, Cleveland Clinic Diabetes Day acts as my trusted filter and synthesis. It tells me what’s truly practice-changing and what’s just noise. An essential investment in my clinical confidence.”
Dr. Karen D., Internal Medicine –
“The focus on health equity and overcoming systemic barriers to technology and medication access was powerful and necessary. It challenged me to audit my own practice and advocate more effectively for my patients.”
Dr. Robert F., Cardiologist with a metabolic focus –
“If you manage diabetes in 2025, you need this update. The pace of change is staggering. This course ensures you won’t be left prescribing yesterday’s regimens with yesterday’s goals.”